Navigation Links
DNA end caps may lead to cancer treatments, UT Southwestern researchers report

The two ends of human DNA have different structures that are treated differently as a cell divides, UT Southwestern Medical Center researchers have found in a study that could help lead to cancer therapies.

The study ?published in the Feb. 3 issue of the journal Molecular Cell ?focuses on the ends of DNA, which are capped by segments called telomeres. Each time the cell divides, the telomeres shorten. When they become too short, the aging cell can no longer divide. But in most cancer cells, an enzyme called telomerase keeps the telomeres from shortening, making the cells immortal and potentially malignant.

"Drugs that influence these mechanisms might be used to slow replicative aging in normal cells and increase the efficacy of telomerase-inhibition therapies for cancer," said Dr. Woodring Wright, professor of cell biology.

In human cells, every chromosome has a telomere at each end, and each telomere ends in a single-stranded overhang. (DNA is normally double-stranded.) The overhang at one end of the chromosome is longer than at the other.

"Understanding the structure of the overhang is clearly very important for our ultimate ability to understand and manipulate these things for a variety of purposes," Dr. Wright said.

The researchers believe that the rate of shortening is influenced by the length of the overhang ?more DNA is lost from ends that have longer overhangs. Telomerase also changed the relative size of the two tails.

"We need to understand how this size is regulated, since we would like to be able to manipulate it for therapeutic purposes," he said.

Dr. Wright and his collaborator, Dr. Jerry Shay, professor of cell biology, are world-renowned for their work on telomeres and telomerase. They helped develop an anti-telomerase drug that helps slow the spread of lung cancer cells in mice. The drug is being tested in humans to see if it's safe.

The researchers say that any anti-telomerase dr ug would not be used alone to treat cancer. Rather, it would be used in conjunction with more traditional treatments, such as surgery or chemotherapy, to ensure that any cells not killed by those treatments don't spread to other tissues.

Other UT Southwestern researchers involved in the study were Dr. Weihang Chai, instructor of cell biology, and former senior research associate Qun Du, now with Cumbre Inc.


'"/>

Source:UT Southwestern Medical Center


Related biology news :

1. Viral DNA sequence a possible trigger for breast cancer
2. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
3. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
4. Columbia research lifts major hurdle to gene therapy for cancer
5. Combination therapy boosts effectiveness of telomere-directed cancer cell death
6. Mitochondrial DNA mutations play significant role in prostate cancer
7. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
8. BRCA1 causes ovarian cancer through indirect, biochemical route
9. Researchers identify target for cancer drugs
10. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
11. First atlas of key brain genes could speed research on cancer, neurological diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... ... August 21, 2019 , ... AbSci, a revolutionary synthetic ... low-cost biomanufacturing of complex protein therapeutics, today announced the appointment of Fred Larimore, ... Board, Dr. Larimore brings more than 30 years of experience in biopharmaceutical manufacturing ...
(Date:8/15/2019)... ... ... Deep Science Ventures (DSV), a new paradigm for applied science, today announced ... 100 companies over the next 10 years to address the urgent need for new ... was founded to create a better method for launching science companies; one that takes ...
(Date:8/14/2019)... (PRWEB) , ... August 14, 2019 , ... ... characterization, announced today that they have opened a Customer Experience Center (CEC) and ... need for the new office. , The Munich CEC will be a place ...
Breaking Biology News(10 mins):
(Date:8/29/2019)... ... August 28, 2019 , ... DuPont Nutrition & Biosciences ... attendees at the International Baking Industry Expo, September 8 to 11, in booth ... efficiency to cost and waste reduction and from maintaining freshness throughout shelf life ...
(Date:8/27/2019)... ... August 27, 2019 , ... ... pleased to announce it has promoted Consulting Engineer, Robert Battista, to Senior Consulting ... the responsibility of onboarding and mentoring new engineers as well as the creation ...
(Date:8/23/2019)... ... August 22, 2019 , ... ... delivery modalities and is scheduled to broadcast 4Q/2019. Check your local listings for ... skin patches for generic drug delivery. Focusing on therapeutics for children and the ...
(Date:8/14/2019)... ... August 13, 2019 , ... ... focus on prepackaged mobile phases for QC laboratories. After gaining a few significant ... laboratory sciences approach into a valued supplier of manufacturing processing solutions, including reagents ...
Breaking Biology Technology: